NextGen Healthcare Reports Q4 2023 Earnings and Fiscal 2024 Outlook
NextGen Healthcare reports Q4 earnings, with non-GAAP EPS of $0.31 and revenue of $178.6M, and issues fiscal 2024 outlook.
Clever Leaves Partners with SOMAÍ Pharmaceuticals to Supply EUGMP Certified CBD Extracts from Colombia to Portugal
Clever Leaves Holdings Inc. has signed a five-year agreement with SOMAÍ Pharmaceuticals to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. Clever
Exelixis presents at Bank of America Securities 2023 Healthcare Conference
Exelixis, Inc. presents at Bank of America Securities 2023 Healthcare Conference on May 10, 2023. The company also released its Q1 earnings report
Exelixis presents at Bank of America Securities 2023 Healthcare Conference
Exelixis, Inc. presents at Bank of America Securities 2023 Healthcare Conference on May 10, 2023. The company also released its Q1 earnings report
Utah Medical Products, Inc. Approves 1.7% Increase in Quarterly Cash Dividend for Shareholders
Utah Medical Products, Inc. approves 1.7% increase in quarterly cash dividend to $0.295 per share for stockholders on record as of June 16
Janssen to Showcase Advances in Cancer Care at ASCO and EHA with 90+ Presentations on Portfolio and Pipeline
Janssen, a Johnson & Johnson company, will present over 90 scientific advances in cancer care at ASCO and EHA conferences. More than 15 oral presentations and
HealthStream Reports Q1 2023 Earnings Results and Reaffirms Revenue Outlook
HealthStream, Inc. reports Q1 2023 earnings with flat earnings and increased revenue, reaffirms 2023 revenue outlook. Analyst recommendations are outperform.
The Ensign Group reports Q1 2023 earnings, raises revenue outlook.
The Ensign Group Inc. reports Q1 2023 earnings, with increased revenue and raised 2023 annual guidance. RBC lifts price target to $108 from $
Royalty Pharma Presents at Bank of America Healthcare Conference, Morgan Stanley Adjusts Price Target.
Royalty Pharma presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 0220 PM. Morgan Stanley adjusts price target on Royalty Pharma
Acadia Healthcare Announces Judith Scimone as Chief Human Resources Officer to Advance People Strategy and Solidify Position as Premier Employer
Acadia Healthcare Company Inc. has appointed Judith Scimone as its Chief Human Resources Officer, responsible for shaping and advancing the company’s people strategy to solidify its position as
IQVIA VP Sheetal Telang Honored with 2023 Rising Star Award by Healthcare Businesswomans Association
IQVIA’s Sheetal Telang, VP of Therapeutic Strategy, has been awarded the 2023 Rising Star award by the Healthcare Businesswoman’s Association (HBA
Zhongchao Inc. Partners with Ximalaya for Health Knowledge Popularization and Disease Prevention Advocacy
Zhongchao Inc. announces a strategic cooperation agreement with Shanghai Ximalaya Technology Co., Ltd. to improve health knowledge popularization and disease prevention advocacy through precision communication and
Azenta, Inc. Forecasts Revenue of $645675 Million for 2023 with $100 Million from B Medical
Azenta, Inc. forecasts full-year revenue of $645M to $675M for 2023, including $100M from B Medical.
UnitedHealthcare Community Plan of North Carolina Announces $275,000 in Grants to Support Children in Kinship and Foster Care
UnitedHealthcare Community Plan of North Carolina has granted $275,000 to three local organizations in the state to support kinship and foster care children. The funds will help Methodist
Exact Sciences Corporation presents at Bank of America Securities 2023 Healthcare Conference
Exact Sciences Corporation presented at Bank of America Securities 2023 Healthcare Conference, discussing the company’s developments in life sciences and diagnostics tools. Citigroup adjusted the price target on Exact
DaVita Honors Nephrology Nurses with DAISY Award for Extraordinary Care
DaVita Inc. recognizes 56 of its nephrology nurses with the DAISY Award for Extraordinary Nurses during National Nurses Week, honoring those who provide outstanding,
Company Completes Repurchase of 3.23% Shares for $12 Million
The company completed the repurchase of 3,250,193 shares for $12 million under its buyback plan announced on November 4, 2020.
Xenon Pharmaceuticals to Present at BofA Securities Health Care Conference 2023
Xenon Pharmaceuticals Inc. will present at the BofA Securities Health Care Conference 2023 on May 10, 2023, with a live webcast available
Wemostasis Diagnostics partners with Thermo Fisher for worldwide distribution of TCAutomation lab automation system in Hemostasis
Wemostasis Diagnostics has signed a new partnership agreement with Thermo Fisher Scientific for distribution of TCAutomation system in Hemostasis Diagnostics, allowing Werfen to
Gilead Sciences Announces Executive Speaking Engagements at Investor Conferences
Gilead Sciences executives will be speaking at investor conferences on May 9, May 16, and June 12. Live webcasts accessible via investors.gilead.com